These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4826497)

  • 1. Immunologic and chemotherapeutic parameters in a model breast tumor system.
    Rugmann RA; Stolfi RL; Hayworth PE; Martin DS
    Cancer Chemother Rep 2; 1974 Mar; 4(1):25-32. PubMed ID: 4826497
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced cures of spontaneous murine mammary carcinomas with surgery and five-compound combination chemotherapy, and their immunotherapeutic interrelationship.
    Fugmann RA; Martin DS; Hayworth PE; Stolfi RL
    Cancer Res; 1970 Jul; 30(7):1931-6. PubMed ID: 5456078
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA; Lucas ZJ
    J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous murine mammary adenocarcinoma: model system for evaluation of combined methods of therapy.
    Stolfi RL; Martin DS; Fugmann RA
    Cancer Chemother Rep; 1971 Jun; 55(3):239-51. PubMed ID: 4329953
    [No Abstract]   [Full Text] [Related]  

  • 6. Age- and sex-related differences in antibody formation and blastogenic responsiveness of splenocytes from RIII mice developing virus-induced mammary adenocarcinoma.
    Specter S; Friedman H
    J Natl Cancer Inst; 1981 Dec; 67(6):1347-51. PubMed ID: 6273637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron microscope study of antigens in cells of mouse mammary tumor cell lines by peroxidase-labeled antibodies in sera of mammary tumor-bearing mice and of patients with breast cancer.
    Hoshino M; Dmochowski L
    Cancer Res; 1973 Nov; 33(11):2551-61. PubMed ID: 4355972
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of Ukrain on patients with surgically treated breast cancer. Part III. The immune system.
    Fomin KA; Uglyanica KN; Nefyodov LI; Djurd TI; Nowicky JW; Brzosko WJ; Jankowski A
    Drugs Exp Clin Res; 1996; 22(3-5):143-5. PubMed ID: 8899318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
    Orsolić N; Basić I
    Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition.
    Fisher B; Soliman O; Fisher ER
    Cancer Res; 1970 Jul; 30(7):2035-42. PubMed ID: 4917210
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy before mastectomy may be a more effective therapeutic sequence than its reverse in primary operable breast cancer.
    Papaioannou AN
    Eur J Cancer (1965); 1980; Suppl 1():255-8. PubMed ID: 7032938
    [No Abstract]   [Full Text] [Related]  

  • 12. The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma.
    Haskill JS; Key M; Radov LA; Parthenais E; Korn JH; Fett JW; Yamamura Y; DeLustro F; Vesley J; Gant G
    J Reticuloendothel Soc; 1979 Oct; 26(4):417-25. PubMed ID: 316009
    [No Abstract]   [Full Text] [Related]  

  • 13. Human carcinoma-associated precursor antigens of the blood group MN system and the host's immune responses to them.
    Springer GF; Desai PR; Murthy MS; Tegtmeyer H; Scanlon EF
    Prog Allergy; 1979; 26():42-96. PubMed ID: 386359
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of antilymphocyte serum on the growth rate and response to cytotoxic therapy of mammary tumour in mice.
    Bullen BR; Russell CW; Giles GR
    Clin Oncol; 1978 Dec; 4(4):339-45. PubMed ID: 729223
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy, and immunotherapy.
    Martin DS; Hayworth PE; Fugmann RA
    Cancer Res; 1970 Mar; 30(3):709-16. PubMed ID: 5425293
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological tumor--host relationships in mice].
    Müller M; Welcker ER; Schlotterhoss I; Henker J
    Allerg Asthma (Leipz); 1969; 15(3):157-62. PubMed ID: 4906036
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antigens associated with human breast carcinoma].
    Kriukova IN; Vasilevskaia LN
    Vopr Onkol; 1975; 21(2):52-6. PubMed ID: 805495
    [No Abstract]   [Full Text] [Related]  

  • 18. Can neo-adjuvant chemotherapy prevent residual tumors?
    Bourut C; Chenu E; Mathé G
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():59-63. PubMed ID: 2977811
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological problems in radiotherapy and adjuvant cytostatic chemotherapy of breast cancer].
    Pusztai-Markos Z
    Fortschr Med; 1979 Mar; 97(11):487-93. PubMed ID: 369967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immunocompetence in adenocarcinoma of the breast].
    Shohat B; Kott A; Joshua H; Urca I
    Harefuah; 1975 Dec; 89(12):549-50. PubMed ID: 1218830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.